Julie McAuley1, Claire Fraser2, Elena Paraskeva2, Elizabeth Trajcevska2, Michelle Sait3, Nancy Wang1, Eric Bert4, Damian Purcell1, Richard Strugnell5. 1. Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia. 2. Media Production Unit, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, 3000, Australia. 3. Microbiological Diagnostic Unit, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute of Infection and Immunity, Melbourne, 3000, Australia. 4. 3DMeditech, 44 Cook Street, Port Melbourne, 3207, Australia. 5. Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia. rastru@unimelb.edu.au.
Abstract
INTRODUCTION: The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained. METHODS: VTM was prepared using different methods of sterilization then 'spiked' with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR. RESULTS: The best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4 °C, and tested within 48 h. The filtered VTM also supported PCR-based diagnosis for at least 5 days when the mock inoculated VTM was held at room temperature. DISCUSSION: The manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants.
INTRODUCTION: The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained. METHODS:VTM was prepared using different methods of sterilization then 'spiked' with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR. RESULTS: The best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4 °C, and tested within 48 h. The filtered VTM also supported PCR-based diagnosis for at least 5 days when the mock inoculated VTM was held at room temperature. DISCUSSION: The manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants.
Entities:
Keywords:
Culture; Diagnosis; SARS-CoV-2; Transport media; VTM
Authors: Syed M Adil; Sarah E Hodges; Lefko T Charalambous; Musa Kiyani; Beiyu Liu; Hui-Jie Lee; Beth A Parente; John R Perfect; Shivanand P Lad Journal: J Med Microbiol Date: 2020-11-18 Impact factor: 2.472
Authors: Kirsty L Buising; Deborah Williamson; Benjamin C Cowie; Jennifer MacLachlan; Elizabeth Orr; Christopher MacIsaac; Eloise Williams; Katherine Bond; Stephen Muhi; James McCarthy; Andrea B Maier; Louis Irving; Denise Heinjus; Cate Kelly; Caroline Marshall Journal: Med J Aust Date: 2020-11-15 Impact factor: 12.776
Authors: Carlos Barrera-Avalos; Roberto Luraschi; Eva Vallejos-Vidal; Maximiliano Figueroa; Esteban Arenillas; Daniela Barría; Felipe Hernández; Carlos Mateluna; Javier Mena; Claudia Rioseco; Claudia Torrent; Claudio Vergara; Gaby Gutiérrez; Javiera Quiroz; Javiera Alarcón; Julio Cartagena; Javiera Cayunao; Andrea Mella-Torres; Álvaro Santibañez; Sebastián Tapia; Alejandro Undurraga; Deborah Vargas; Valentina Wong; Ailen Inostroza-Molina; Daniel Valdés; Mónica Imarai; Claudio Acuña-Castillo; Felipe E Reyes-López; Ana M Sandino Journal: J Med Virol Date: 2021-11-15 Impact factor: 20.693
Authors: Lorenzo H Salamanca-Neita; Óscar Carvajal; Juan Pablo Carvajal; Maribel Forero-Castro; Nidya Alexandra Segura Journal: Trop Med Infect Dis Date: 2022-09-10
Authors: Matthew J Mears; Michael J Wallace; Jacob S Yount; Lorri A Fowler; Penny S Jones; Peter J Mohler; Loren E Wold Journal: MethodsX Date: 2021-06-30